Trifluoroacetic acid → HCID 178509936, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH2:8][NH:9][C:10]([C:12]2[N:13]=[CH:14][N:15](C(C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)[CH:16]=2)=[O:11])=[C:4]([F:36])[C:3]=1[O:37][C:38]1[CH:43]=[C:42]([C:44]#[N:45])[CH:41]=[C:40]([Cl:46])[CH:39]=1.[C:47]([OH:53])([C:49]([F:52])([F:51])[F:50])=[O:48]>C(Cl)Cl>[F:50][C:49]([F:52])([F:51])[C:47]([OH:53])=[O:48].[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH2:8][NH:9][C:10]([C:12]2[N:13]=[CH:14][NH:15][CH:16]=2)=[O:11])=[C:4]([F:36])[C:3]=1[O:37][C:38]1[CH:43]=[C:42]([C:44]#[N:45])[CH:41]=[C:40]([Cl:46])[CH:39]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
N-({4-Chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-1-(triphenylmethyl)-1H-imidazole-4-carboxamide (0.145 g, 0.22 mmol) was dissolved in CH2Cl2 (3 mL) and TFA (3 mL) added. The solution was stirred for 2.5 h. The solvent was evaporated. Purification was accomplished by Reverse-Phase HPLC (water/acetonitrile with 0.1% TFA) to afford the title compound (0.070 g, 60%) as a white solid. 1H NMR (400 MHz, DMSO-d6): δ ppm 9.01 (br. s., 1H), 8.53 (br. s., 1H), 7.94 (s, 1H), 7.83 (s, 1H), 7.45-7.54 (m, 4H), 7.38 (t, 1H), 4.54 (d, 2H). MS: m/z 405.0 (M+1).
Workup
- customThe solvent was evaporated
- customPurification
Sources & evidence
- ORD record
- ord-af8ebd343aa54eaf9ca0af79febe9aef
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08304419B2
Reaction notes
Loading…